Bayer, BridgeBio in big-bucks deal with heart failure drug

The deal is a win for BridgeBio and CEO Neil Kumar and represents one of the first wins for Bayer CEO Bill Anderson a year into his tenure.

Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 4, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news